# Macrilen

NDC: 0169-1401
Generic name: Macimorelin acetate
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GRANULE, FOR SOLUTION
Routes: ORAL
Marketing started: 20220131
Marketing ended: 20270228
FDA application: NDA205598

## Active ingredients

- MACIMORELIN: 60 mg/mg

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-1401"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-1401
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6034c9b8-5a36-4961-a5dd-11ebf7bdab78